Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine

PHASE2RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

February 2, 2022

Primary Completion Date

August 1, 2026

Study Completion Date

April 1, 2027

Conditions

Aneurysmal Subarachnoid HemorrhageDelayed Cerebral Ischemia

Interventions

DRUG

Nadroparin Injectable Product

high dose LMWH compared to prophylactic dose LMWH

Trial Locations (1)

RECRUITING

Amsterdam University Medical Centers, Amsterdam

All Listed Sponsors

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER